CAA 2026 Unpacked: Compliance, Compensation & Fiduciary Responsibility

About this episode

David Saltzman interviews Jennifer Berman to discuss the key provisions of the Consolidated Appropriations Act (CAA) 2026 and its implications for health plan vendors and sponsors.

In this episode of Healthcare Happy Hour, David Saltzman sits down with Jennifer Berman, chief legal officer of Lumelight, to break down the key provisions of the Consolidated Appropriations Act (CAA) 2026. The discussion focuses on expanded transparency requirements, including new prescription drug reporting and significant changes to compensation disclosure rules impacting brokers, TPAs, and other health plan vendors. Jennifer also explores the growing fiduciary responsibilities for plan sponsors, increased litigation risk, and the need for structured governance and documentation. The conversation highlights both the challenges and opportunities these evolving regulations present for plan sponsors, vendors, and advisors.

People in this episode

Host: David Saltzman

Guest: Jennifer Berman

Topics covered

• Consolidated Appropriations Act
• transparency requirements
• prescription drug reporting
• compensation disclosure
• fiduciary responsibilities
• litigation risk
• governance
• health plan vendors

Keywords

• healthcare
• regulations
• plan sponsors
• advisors

More episodes of Healthcare Happy Hour

• Medical Gaslighting, Patient Advocacy & Reclaiming Your Voice in Healthcare · June 11, 2026
• From Ideas to Action: How NABIP Members Are Shaping Employer Health Policy · June 4, 2026
• ACA Marketplace Final Rule: Fraud Prevention, Enrollment & Broker Impact · May 28, 2026
• The Power of “Yes, And” in Sales and Leadership · May 21, 2026
• AI, Cyber Threats & the Next Era of Benefits Advising · May 14, 2026
• From Capitol Hill to the Client: How Policy Shapes Retirement & Healthcare · April 30, 2026